Science Intellia Updates on In Vivo Gene Editing at ESGCT 2025 in Seville In a significant presentation at the European Society of Gene and Cell Therapy (ESGCT) held in Seville, Intellia Therapeutics provided an update on its... Editorial3 hours ago